Daily oral medication for weight loss in adults with obesity and type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study tests a once-a-day pill for adults who are overweight or have obesity and also have type 2 diabetes. The goal is to see if the medication helps with weight loss and improves blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- Your body mass index (BMI) is 27 or higher.
- You have type 2 diabetes, and your blood sugar test (HbA1c) is above 6.5% but not higher than 10.5%.
- You have tried to lose weight through dieting at least once without lasting success.
- You have not had type 1 diabetes, diabetic coma, or any other type of diabetes except type 2.
- You have not had significant weight changes (more than 11 pounds) in the last 3 months, and you have no history of pancreatitis or certain thyroid conditions.
- You are not allergic to GLP-1 medications, which are drugs used for diabetes and weight loss.
- You are not currently participating in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a once-daily pill called ASC30 to help adults with obesity or overweight who also have conditions like high blood pressure, sleep apnea, or heart disease lose weight. The pill may work by affecting appetite and blood sugar, and the study aims to see how effective and safe it is.
This study tests a new daily pill (aleniglipron) to help adults with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be a good fit if you have a BMI of 27 or higher and your diabetes is managed with A1c between 6.5% and 10%.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This study tests a new oral medication called ACCG-2671 to see how safe it is and how your body handles it. It's an early-stage trial, so the main focus is on safety and tolerability. The study has different parts: one for people with normal weight and one for people with higher weight who are already taking a GLP-1 injection for weight loss.
This study tests an injectable medication called ASC35 to see if it is safe and tolerable for people who are overweight or obese. It may help with weight management, though it is an early-stage trial focused on safety first.
This study tests whether a GLP-1 medication (a type of drug that helps with weight loss) can safely and effectively help young adults with type 1 diabetes who also have obesity. It aims to see if adding this treatment to insulin can improve weight and blood sugar control.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.